Anesiva, Inc.
Anesiva Announces South Korea FDA Approval of Adlea Investigational New Drug Application
Published in Medical Device Business Week, June 18th, 2008
Anesiva, Inc. (NASDAQ:ANSV) announced that the South Korea Food and Drug Administration has approved Anesiva's investigational new drug application for Adlea(TM), the company's long-acting, site specific, non-opioid drug candidate in Phase 3 clinical development for the management of acute pain following orthopedic surgery. Anesiva plans to initiate a Phase 2 clinical trial of Adlea in patients undergoing arthroscopic shoulder surgery in South Korea this summer.
"We selected South Korea for this Adlea clinical trial because the standards of care in orthopedic surgery and the professional training of its clinicians are similar to those in the United States," said John...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Abbott
Abbott Submits Application for Approval of XIENCE V Everolimus Eluting Coronary Stent System in Japan - Abiomed, Inc.
Abiomed Receives 510k Clearance from FDA for Impella 2.5 Device - AcuNetx Inc.
AcuNetx Announces Retirement of Chairman, Founder - Aethlon Medical, Inc.
The Aethlon Hemopurifier Proves Effective in Capturing the Reconstructed Spanish Flu of 1918 and H5N1 Avian Influenza Virus - American Red Cross - Southeastern Michigan Chapter
American Red Cross of Southeastern Michigan Celebrates National CPR/AED Awareness Week - Anesthesia
European Union's CHMP Issues Positive Opinion on Sugammadex - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
